Clinical Effect of Finasteride Combined with Transurethral Plasma Resection of Prostate in Treatment of Patients with Benign Prostatic Hyperplasia
Objective To explore effect of finasteride patients combined with transurethral plasma resection on prostate with benign prostatic hyperplasia.Methods The paper reviewed and chose data of 86 patients with benign prostatic hyperplasia admitted to our hospital from June 2020 to March 2023.43 cases in control group were treated with prostate plasma resection,oral sustained-release capsules of tamsulosin hydrochloride,and oral administration of 5mg/tablet of finasteride tablets;43 cases in observation group with prostate plasma resection,oral administration of tamsulosin hydrochloride sustained-release capsules,and oral administration of 10mg/tablet of finasteride.I-PSS scores,life quality,lower urinary tract symptoms,surgical and clinical indicators,and adverse reactions were compared between two groups.Results There was no difference in I-PSS scores between two groups before treatment(P＞0.05),and average severity of lower urinary tract symptoms reached moderate.After treatment,I-PSS scores of observation group were lower than control group(P＜0.05),and average severity of lower urinary tract symptoms reached mild,while control group remained moderate.Life quality scores of observation group after treatment were higher than control group(P＜0.05).in traoperative bleeding volume,surgical time,and intraoperative flushing fluid volume in observation group was lower/shorter than control group(P＜0.05).There was no difference in weight of excised prostate between two groups(P＞0.05).Observation group had shorter postoperative catheter removal time than control group,and maximum urine flow rate was higher than control group(P＜0.05).in cidence of adverse reactions in observation group was lower than control group(P＜0.05).Conclusion Preoperative oral administration of 10mg/tablet of finasteride followed by Plasma prostatectomy can alleviate clinical symptoms,improve life quality,and reduce postoperative adverse reactions of patients with benign prostatic hyperplasia.
NETL
NSTL
万方数据
